IDXG · Interpace Biosciences, Inc. · Documents
Market Cap
$42.19M
Shares
5.54M
Volume · Feb 25
186.4K
Avg daily vol (3M)
—
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 10-K | — | 2021-04-01 | 2020-12-31 | |
| 8-K | — | 2021-02-25 | 2021-02-24 | |
| 8-K | — | 2021-02-17 | 2021-02-16 | |
| 8-K | — | 2021-02-04 | 2021-01-31 | |
| 8-K | — | 2021-01-20 | — | |
| 10-Q | — | 2021-01-20 | 2020-09-30 | |
| 10-K/A | — | 2021-01-19 | 2019-12-31 | |
| 10-Q/A | — | 2021-01-19 | 2020-06-30 | |
| 10-Q/A | — | 2021-01-19 | 2020-03-31 | |
| 8-K | — | 2021-01-11 | 2021-01-05 | |
| 8-K | — | 2020-12-08 | 2020-12-07 | |
| 8-K | — | 2020-11-25 | 2020-11-23 | |
| 8-K | — | 2020-11-19 | 2020-11-18 | |
| NT 10-Q | — | 2020-11-17 | 2020-09-30 | |
| 8-K | — | 2020-10-23 | 2020-10-19 | |
| 8-K | — | 2020-10-20 | — | |
| 10-Q | — | 2020-10-19 | 2020-06-30 | |
| 8-K | — | 2020-10-14 | — | |
| 8-K | — | 2020-08-20 | 2020-08-18 | |
| NT 10-Q | — | 2020-08-14 | 2020-06-30 | |
| 8-K | — | 2020-08-14 | — | |
| 8-K | — | 2020-07-14 | 2020-07-09 | |
| 10-Q | — | 2020-06-26 | 2020-03-31 | |
| 8-K | — | 2020-06-25 | — | |
| DEF 14A | — | 2020-06-10 | 2020-06-09 | |
| 8-K | — | 2020-06-09 | 2020-06-03 | |
| 10-K/A | — | 2020-05-29 | 2019-12-31 | |
| PRE 14A | — | 2020-05-20 | 2020-05-19 | |
| 8-K | — | 2020-05-15 | — | |
| 8-K | — | 2020-05-05 | 2020-04-29 | |
| 8-K | — | 2020-04-27 | — | |
| 10-K | — | 2020-04-22 | 2019-12-31 | |
| 8-K | — | 2020-04-22 | — | |
| 8-K | — | 2020-03-30 | — | |
| 8-K | — | 2020-01-31 | 2020-01-29 | |
| 8-K/A | — | 2020-01-28 | 2020-01-15 | |
| 8-K | — | 2020-01-28 | 2020-01-22 | |
| 8-K | — | 2020-01-17 | 2020-01-15 | |
| 8-K | — | 2020-01-14 | 2020-01-10 | |
| 8-K | — | 2020-01-14 | — |
Showing 101–140 of 140 filings